Skip to main content

JPMORGAN CHASE & CO

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 19617 NEW YORK, NY

Position in NAMS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$38,395,842
+$10,091,706 QoQ
Shares Held
1,132,955
+28.1% QoQ
Ownership
0.948%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 197 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in NAMS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. NAMS ranks #42 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NAMS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,395,842 1,132,955
2026-03-31 $28,304,136 884,228
2025-12-31 $35,079,156 999,976
2025-09-30 $37,043,041 1,302,498
2025-06-30 $26,420,623 1,458,897
2025-03-31 $20,292,277 991,318
2024-12-31 $1,567,108 60,977
2024-09-30 $371,026 22,351
2024-06-30 $155,043 8,071
2024-03-31 $102,144 4,319
2023-09-30 $24,253 2,622
2023-06-30 $136,295 11,463
2023-03-31 $296,586 22,367
2022-12-31 $12,011 1,102